{
  "url": "https://openlegislation.uk/eu-regulation-2019-1966/annex-I",
  "json_url": "https://openlegislation.uk/eu-regulation-2019-1966/annex-I.json",
  "legislation": "eur/2019/1966",
  "legislation_title": "Commission Regulation (EU) 2019/1966 of 27 November 2019 amending and correcting Annexes II, III and V to Regulation (EC) No 1223/2009 of the European Parliament and of the Council on cosmetic products (Text with EEA relevance)",
  "legislation_url": "https://openlegislation.uk/eu-regulation-2019-1966",
  "path": "annex/I",
  "kind": "annex",
  "number": "I",
  "heading": null,
  "text": "Reference number\nSubstance identification\nChemical name/INN\nCAS number\nEC number\na\nb\nc\nd\n‘1612\nPhosmet (ISO); S-[(1,3-dioxo-1,3-dihydro-2H- isoindol-2-yl)methyl]-O,O-dimethyl phosphorodithioate;\nO,O-dimethyl-S-phthalimidomethyl phosphorodithioate\n732-11-6\n211-987-4\n1613\nPotassium permanganate\n7722-64-7\n231-760-3\n1614\n2-Benzyl-2-dimethylamino-4′- morpholinobutyrophenone\n119313-12-1\n404-360-3\n1615\nQuizalofop-p-tefuryl (ISO);\n(+/–) tetrahydrofurfuryl (R)-2-[4-(6- chloroquinoxalin-2-\nyloxy)phenyloxy]propionate\n200509-41-7\n414-200-4\n1616\nPropiconazole (ISO); (2RS,4RS;2RS,4SR)-1-{[2-(2,4- dichlorophenyl)-4-propyl-1,3- dioxolan-2-yl]methyl}-1H- 1,2,4-triazole\n60207-90-1\n262-104-4\n1617\nPinoxaden (ISO); 8-(2,6-diethyl-4-methylphenyl)-7-oxo-1,2,4,5-tetrahydro-7H-pyrazolo[1,2-d][1,4,5]oxadiazepin-9-yl 2,2-dimethylpropanoate\n243973-20-8\n635-361-9\n1618\nTetramethrin (ISO);\n(1,3-dioxo-1,3,4,5,6,7-hexahydro-2H-isoindol-2-yl)methyl 2,2-dimethyl-3-(2-methylprop-1-en-1-yl)cyclopropanecarboxylate\n7696-12-0\n231-711-6\n1619\n(1,3,4,5,6,7-Hexahydro-1,3-dioxo-2H-isoindol-2-yl)methyl (1R-trans)-2,2-dimethyl-3-(2- methylprop-1-enyl)cyclopropanecarboxylate\n1166-46-7\n214-619-0\n1620\nSpirodiclofen (ISO);\n3-(2,4-dichlorophenyl)-2-oxo- 1-oxaspiro[4.5]dec-3-en-4-yl 2,2-dimethylbutyrate\n148477-71-8\n604-636-5\n1621\nReaction mass of 1-[2-(2-aminobutoxy)ethoxy]but-2-ylamine and 1-({[2-(2-aminobutoxy)ethoxy]methyl}propoxy) but-2-ylamine\n897393-42-9\n447-920-2\n1622\n1-Vinylimidazole\n1072-63-5\n214-012-0\n1623\nAmisulbrom (ISO)3-(3-bromo-6-fluoro-2-methylindol-1-ylsulfonyl)-N,N-dimethyl-1H-1,2,4-triazole-1-sulfonamide\n348635-87-0\n672-776-4’\nFor use as a preservative see Annex V, No 3.\nSolely for products which might be used for children under 3 years of age.’\n‘98\nBenzoic acid, 2-hydroxy-\nSalicylic acid\n69-72-7\n200-712-3\n(a) Rinse-off hair products\n(b) Other products except body lotion, eye shadow, mascara, eyeliner, lipstick, roll-on deodorant\n(a) 3,0 %\n(b) 2,0 %\nNot to be used in preparations for children under 3 years of age.\nNot to be used in applications that may lead to exposure of the end-user’s lungs by inhalation.\nNot to be used in oral products.\nFor purposes other than inhibiting the development of micro-organisms in the product. This purpose has to be apparent from the presentation of the product.\nNot to be used for children under 3 years of age\nFor uses other than preservative, see Annex III, No 98.\nSolely for products which might be used for children under 3 years of age\nSolely for products which might be used for children under 3 years of age and which remain in prolonged contact with the skin.’\nReference number\nSubstance Identification\nConditions\nWording of conditions of use and warnings\nChemical name/INN\nName of Common Ingredients Glossary\nCAS number\nEC number\nProduct type, Body parts\nMaximum concentration in ready for use preparation\nOther\na\nb\nc\nd\ne\nf\ng\nh\ni\n‘3\nSalicylic acid and its salts\nSalicylic acid\nCalcium salicylate, magnesium salicylate, MEA- salicylate, sodium salicylate, potassium salicylate, TEA- salicylate\n69-72-7\n824-35-1, 18917-89-0, 59866- 70-5, 54-21-7, 578-36-9, 2174-16-5\n200-712-3\n212-525-4, 242-669-3, 261-963-2, 200-198-0, 209-421-6, 218-531-3\n0,5 % (acid)\n0,5 % (acid)\nNot to be used in products for children under 3 years of age.\nNot to be used in oral products.\nNot to be used in applications that may lead to exposure of the end-user’s lungs by inhalation.\nNot to be used in products for children under 3 years of age, except for shampoos.\nNot to be used for children under 3 years of age\nNot to be used for children under 3 years of age",
  "extent": "E+W+S+N.I.",
  "status": null,
  "version": "current",
  "annotations": [
    {
      "type": "footnote",
      "label": "f1",
      "text": "For use as a preservative see Annex V, No 3."
    },
    {
      "type": "footnote",
      "label": "f2",
      "text": "Solely for products which might be used for children under 3 years of age.’"
    },
    {
      "type": "footnote",
      "label": "f3",
      "text": "For uses other than preservative, see Annex III, No 98."
    },
    {
      "type": "footnote",
      "label": "f4",
      "text": "Solely for products which might be used for children under 3 years of age"
    },
    {
      "type": "footnote",
      "label": "f5",
      "text": "Solely for products which might be used for children under 3 years of age and which remain in prolonged contact with the skin.’"
    }
  ],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/eur/2019/1966/annex/I",
    "retrieved_at": "2026-11-01T14:43:01.053450+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}